TM4SF5 and malignant colon neoplasm: To evaluate the significance of TM4SF5 as a target in colon cancer metastasis control in mice, we first immunized BALB/c mice with the TM4SF5 peptide vaccine composed of the cyclic TM4SF5 peptide (hTM4SF5EC2-C) and Lipoplex(O).